OnDemand WTP Pricing Research

Trump administration preps executive order on price transparency as lawmakers converge | WSJ

In a po­lit­i­cal sphere where Re­pub­li­cans and De­moc­rats can find lit­tle com­mon ground, the pharma in­dus­try in gen­eral — and price trans­parency in par­tic­u­lar — has pre­sented a rare op­por­tu­nity for bi­par­ti­san agree­ment.

A slew of trans­parency bills are wind­ing their way through con­gres­sional cir­cles, with au­thors from both sides of the po­lit­i­cal aisles. And now the Wall Street Jour­nal re­ports that pharma Critic-​in-Chief Don­ald Trump is prep­ping an ex­ec­u­tive or­der that would re­quire that con­sumers have ac­cess to the rates that have been ne­go­ti­ated through­out the sys­tem.

The Jour­nal re­ports that their sources tell them meet­ings to­day are planned to re­view the new ex­ec­u­tive or­der — which could mark the end of a long era of pri­vate deals and price con­fu­sion, as pub­lic anger over out-​of-pocket ex­penses con­tin­ues to sim­mer.

Read complete article here:

Trump administration preps executive order on price transparency as lawmakers converge — WSJ – Endpoints News.

Post a Comment

WP-SpamFree by Pole Position Marketing